Status:
COMPLETED
Novelty, Conformity and Trust in COVID-19 Vaccines
Lead Sponsor:
National University of Singapore
Conditions:
Trust
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite their established benefits as public measures, vaccines continue to be treated with suspicion by many people, in the US and other parts of the world (Larson et al. 2014; Olive et al. 2018; Laz...
Detailed Description
The investigators study the role of trust in COVID-19 vaccine through a global survey. Specifically, the investigators vary (1) the degree of vaccine innovation and (2) the adoption rate of the vaccin...
Eligibility Criteria
Inclusion
- Healthy adults over 18 years old
Exclusion
- None
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
35180 Patients enrolled
Trial Details
Trial ID
NCT04693689
Start Date
February 1 2021
End Date
March 30 2021
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SurveyMonkey
San Mateo, California, United States, 94403